Corrections: Social protection and tuberculosis control in 21 European countries, 1995–2012: a cross-national statistical modelling analysis (The Lancet Infectious Diseases (2014) 14(11) (1105–1112)(S1473309914709272)(10.1016/S1473-3099(14)70927-2));Social protection and tuberculosis control in 21 European countries, 1995-2012: A cross-national statistical modelling analysis

The Lancet Infectious Diseases

Volumn 14, Issue 11, 2014, Pages 1105-1112

  Reeves, Aaron ^a   Basu, Sanjay ^b   McKee, Martin ^c   Stuckler, David ^a   Sandgren, Andreas ^d   Semenza, Jan ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EUROPEAN UNION; GOVERNMENT; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INCIDENCE; MIGRATION; MORTALITY; PENSION; PREVALENCE; PROTECTION; PUBLIC HEALTH SERVICE; SOCIAL ASPECT; SOCIAL PROTECTION; STATISTICAL ANALYSIS; TUBERCULOSIS; TUBERCULOSIS CONTROL; ECONOMICS; EUROPE; POLICY; SURVIVAL; TREATMENT OUTCOME;

EUROPE; HUMANS; PREVALENCE; PUBLIC POLICY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84908290305     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30202-5     Document Type: Erratum

References (55)

1. McKeown T The role of medicine: drama, mirage or nemesis? 1979, Blackwell, Oxford.
2. Keshavjee S, Farmer PE Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med 2012, 367:931-936.
3. Draft global strategy and targets for tuberculosis prevention, care and control after 2015 Sixty-seventh World Health Assembly 2014, WHO, World Health Assembly, Geneva.
4. Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843.
5. Geneau R, Stuckler D, Stachenko S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet 2010, 376:1689-1698.
6. Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375:1814-1829.
7. Dheda K, Gumbo T, Gandhi NR, et al. Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2014, 2:321-338.
8. Zumla A, Kim P, Maeurer M, Schito M Zero deaths from tuberculosis: progress, reality, and hope. Lancet Infect Dis 2013, 13:285-287.
9. Atun R, Weil DE, Eang MT, Mwakyusa D Health-system strengthening and tuberculosis control. Lancet 2010, 375:2169-2178.
10. Ståhl T, Wismar M, Ollila E, Lahtinen E, Leppo K Health in all policies: prospects and potentials 2006, Ministry of Social Affairs and Health, Finland.
11. Stuckler D, Basu S, Mckee M, King L Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries. Proc Natl Acad Sci USA 2008, 105:13280-13285.
12. Stuckler D, King LP, Basu S International Monetary Fund programs and tuberculosis outcomes in post-communist countries. PLoS Med 2008, 5:1079-1090.
13. Geng E, Kreiswirth B, Driver C, et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002, 346:1453-1458.
14. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011, 101:654-662.
15. Anderson I Housing, homelessness and the welfare state in the UK. Int J Housing Pol 2004, 4:369-389.
16. Scruggs LA, Allan JP Social stratification and welfare regimes for the twenty-first century revisiting the three worlds of we are capitalism. World Polit 2008, 60:642-664.
17. Scruggs L, Allan JP The material consequences of welfare states-benefit generosity and absolute poverty in 16 OECD countries. Comp Polit Stud 2006, 39:880-904.
18. Biro A Adverse effects of widowhood in Europe. Adv Life Course Res 2013, 18:68-82.
19. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989, 320:545-550.
20. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA 1994, 272:455-461.
21. Global tuberculosis report 2013 WHO, (accessed Aug 1, 2014). http://www.who.int/tb/publications/global_report/en/c.
22. Rajagopalan S, Yoshikawa TT Tuberculosis in the elderly. Z Gerontol Geriatr 2000, 33:374-380.
23. Dooley KE, Chaisson RE Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746.
24. Acevedo-Garcia D Zip code-level risk factors for tuberculosis: neighborhood environment and residential segregation in New Jersey, 1985-1992. Am J Public Health 2001, 91:734-741.
25. Barr RG, Diez-Roux AV, Knirsch CA, Pablos-Mendez A Neighborhood poverty and the resurgence of tuberculosis in New York City, 1984-1992. Am J Public Health 2001, 91:1487-1493.
26. Lonnroth K, Raviglione M Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008, 29:481-491.
27. Horsburgh CR Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004, 350:2060-2067.
28. Cegielski JP, McMurray DN The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004, 8:286-298.
29. Lönnroth K, Williams B, Cegielski P, Dye C A homogeneous dose-response relationship between body-mass index and tuberculosis incidence. Int J Epidemiol 2010, 9:149-155.
30. Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 2009, 80:634-639.
31. Lonnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C Alcohol use as a risk factor for tuberculosis-a systematic review. BMC Public Health 2008, 8:289.
32. Rehm J, Samokhvalov AV, Neuman MG, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009, 9:450.
33. Lefebvre N, Falzon D Risk factors for death among tuberculosis cases: Analysis of European surveillance data. Eur Respir J 2008, 31:1256-1260.
34. Marks GB, Bai U, Simpson SE, Sullivan EA, Stewart GJ Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia-reappraising the estimates of risk. Am J Respir Crit Care Med 2000, 162:1851-1854.
35. Walter ND, Painter J, Parker M, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med 2014, 189:88-95.
36. Coburn D Beyond the income inequality hypothesis: class, neo-liberalism, and health inequalities. Soc Sci Med 2004, 58:41-56.
37. Brady D The welfare state and relative poverty in rich Western democracies, 1967-1997. Soc Forces 2005, 83:1329-1364.
38. Jaramillo E Encompassing treatment with prevention: the path for a lasting control of tuberculosis. Soc Sci Med 1999, 49:393-404.
39. Rasanathan K, Sivasankara Kurup A, Jaramillo E, Lonnroth K The social determinants of health: key to global tuberculosis control. Int J Tuberc Lung Dis 2011, 15(suppl 2):S30-S36.
40. Storla DG, Yimer S, Bjune GA A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008, 8:15.
41. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009, 68:2240-2246.
42. Lundberg O, Yngwe MA, Stjarne MK, et al. The role of welfare state principles and generosity in social policy programmes for public health: an international comparative study. Lancet 2008, 372:1633-1640.
43. Global health observatory: tuberculosis WHO, (accessed Aug 1, 2014). http://www.who.int/gho/tb/en/.
44. General government expenditure by function 2014, EUROSTAT, EUROSTAT, Luxembourg.
45. Manual on sources and methods for the compilation of COFOG statistics: classification of the functions of government (COFOG) 2007, EUROSTAT, EUROSTAT commission, Luxembourg.
46. Stuckler D, Basu S, Suhrcke M, Coutts A, McKee M The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis. Lancet 2009, 374:315-323.
47. Dye C, Garnett GP, Sleeman K, Williams BG Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998, 352:1886-1891.
48. Rieder HL, Cauthen GM, Comstock GW, Snider DE Epidemiology of tuberculosis in the United States. Epidemiol Rev 1989, 11:79-98.
49. Reeves A, Basu S, McKee M, Marmot M, Stuckler D Austere or not? UK coalition government budgets and health inequalities. J R Soc Med 2013, 106:432-436.
50. McKee M, Karanikolos M, Belcher P, Stuckler D Austerity: a failed experiment on the people of Europe. Clin Med 2012, 12:346-350.
51. Lienhardt C From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev 2001, 23:288-301.
52. Ortblad KF, Lozano R, Murray CJL An alternative estimation of tuberculosis incidence from 1980 to 2010: methods from the Global Burden of Disease 2010. Lancet 2013, 381(suppl 2):S104.
53. Stuckler D, Basu S The body economic: why austerity kills 2013, Penguin, London.
54. Kentikelenis A, Karanikolos M, Reeves A, McKee M, Stuckler D Greece's health crisis: from austerity to denialism. Lancet 2014, 383:748-753.
55. Reeves A, McKee M, Basu S, Stuckler D The political economy of austerity and healthcare: cross-national analysis of expenditure changes in 27 European nations 1995-2011. Health Pol 2014, 115:1-8.